Today: 30 June 2026
Sandisk stock rises on chip-shortage bets as SNDK heads into Jan. 29 earnings
5 January 2026
1 min read

Sandisk stock rises on chip-shortage bets as SNDK heads into Jan. 29 earnings

NEW YORK, January 5, 2026, 09:44 EST — Regular session

  • Sandisk shares rose 2.6% in early trading as investors chased memory and storage names on higher-price expectations.
  • Reuters reported a global supply crunch tied to AI infrastructure is tightening availability across memory products.
  • Next focus: Sandisk’s fiscal second-quarter results on Jan. 29 and key U.S. macro data later this week.

Sandisk Corp (SNDK.O) shares rose 2.6% in early trading on Monday, extending a rally in U.S. memory and storage names after reports that chip shortages could translate into higher prices. Micron Technology (MU.O) was up 2.8% and Western Digital (WDC.O) gained 3.1%, Reuters reported.

The move matters because memory pricing can swing quickly when supply tightens. For Sandisk, which sells NAND flash — a type of storage memory used in devices from smartphones to data-center drives — firmer pricing can lift revenue and margins in a business that is notoriously volatile.

Reuters reported that manufacturers have been diverting production capacity toward high-bandwidth memory, or HBM, the ultra-fast chips used in AI servers, leaving less supply for other products. Samsung co-CEO TM Roh called the shortage “unprecedented,” while TrendForce said prices in some segments have more than doubled since February last year; analysts at Morningstar and J.P. Morgan said the upturn — often dubbed a “supercycle,” meaning a longer-than-usual boom — could run into 2027. Reuters

Sandisk last closed at $275.24, around $9.5 below its record high of $284.76 set in November, a zone chart-focused investors often treat as a key test for momentum.

The next company catalyst is Sandisk’s fiscal second-quarter earnings on Jan. 29. The company said it will hold its conference call that day at 1:30 p.m. Pacific time.

Beyond the chip-specific headlines, investors are also weighing a busy U.S. calendar in the opening weeks of January, with employment data due Jan. 9 and a consumer price index report on Jan. 13, Reuters reported.

But the shortage trade cuts both ways. Memory is cyclical, and any sign that AI infrastructure spending is slowing — or that suppliers ramp output faster than expected — can unwind pricing power and hit the group.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Theravance Biopharma (TBPH) Slides 3% After $929M Zymeworks (ZYME) Deal Announced
    June 30, 2026, 10:24 AM EDT. Theravance Biopharma (TBPH) shares slipped about 3% on June 29, 2026, after Zymeworks (ZYME) said it would buy the company in an all-cash deal valued at around $929 million. The deal is set to close in H2 2026. Theravance went up for sale after its main drug, ampreloxetine, missed in Phase III trials. Most of Theravance's revenue came from a single COPD collaboration. The buyout gives shareholders $17 per share, which is a 22% premium to the March 3 close, plus CVRs linked to future ampreloxetine proceeds. Management called the move the best route for shareholder value as operational cuts and slow growth continue. Theravance has a Zacks Rank #4 (Sell).
Hyperscale Data (GPUS) stock jumps 20% in premarket as insider buying keeps spotlight on the microcap
Previous Story

Hyperscale Data (GPUS) stock jumps 20% in premarket as insider buying keeps spotlight on the microcap

SpaceX lines up back-to-back Starlink launches from Florida as orbit crowding comes into focus
Next Story

SpaceX lines up back-to-back Starlink launches from Florida as orbit crowding comes into focus

Go toTop